The effect of rivaroxaban and enoxaparin on the prophylaxis of venous thromboembolism

Phase 2

• Conditions: Knee or hip arthroplasty surgery.; Complications of internal orthopaedic prosthetic devices, implants and grafts

• Registration Number: IRCT20161121031003N4
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

More than 18 years of age
Who are candidate for hip or knee arthroplasty surgery

Exclusion Criteria

Severe side effects of a drug
Moderate to severe hepatic disorder
Cardiovascular diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Deep vein thrombosis. Timepoint: 6, 12, and 24 weeks after the intervention. Method of measurement: Doppler ultrasound.

Secondary Outcome Measures

Name	Time	Method
The side effects of wounds. Timepoint: 6, 12, and 24 weeks after the intervention. Method of measurement: Questionnaire.;Wound infection. Timepoint: 6, 12, and 24 weeks after the intervention. Method of measurement: Questionnaire.;Gastrointestinal complications. Timepoint: 6, 12, and 24 weeks after the intervention. Method of measurement: Questionnaire.;Skin complications. Timepoint: 6, 12, and 24 weeks after the intervention. Method of measurement: Questionnaire.;Severe bleeding. Timepoint: 6, 12, and 24 weeks after the intervention. Method of measurement: Questionnaire.